Clinical trials
Observational trials in Saudi Arabia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
402 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 5 |
| 2005 | 3 |
| 2006 | 3 |
| 2007 | 6 |
| 2008 | 18 |
| 2009 | 12 |
| 2010 | 13 |
| 2011 | 15 |
| 2012 | 12 |
| 2013 | 8 |
| 2014 | 13 |
| 2015 | 17 |
| 2016 | 20 |
| 2017 | 15 |
| 2018 | 20 |
| 2019 | 20 |
| 2020 | 38 |
| 2021 | 32 |
| 2022 | 30 |
| 2023 | 27 |
| 2024 | 22 |
| 2025 | 24 |
| 2026 | 18 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 257 |
| Recruiting | 52 |
| Unknown status | 50 |
| Active, not recruiting | 19 |
| Terminated | 8 |
| Enrolling by invitation | 6 |
| Not yet recruiting | 6 |
| Suspended | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 25 |
| King Faisal Specialist Hospital & Research Center | 23 |
| King Saud University | 23 |
| AstraZeneca | 22 |
| Novo Nordisk A/S | 22 |
| Hoffmann-La Roche | 8 |
| King Abdulaziz University | 8 |
| Novartis Pharmaceuticals | 8 |
| Boston Scientific Corporation | 7 |
| King Abdul Aziz Specialist Hospital | 7 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 19 |
| Breast Neoplasms | 16 |
| COVID-19 | 16 |
| Diabetes Mellitus | 13 |
| Obesity | 12 |
| Atrial Fibrillation | 11 |
| Neoplasms | 10 |
| Asthma | 8 |
| Coronary Artery Disease | 7 |
| Carcinoma, Hepatocellular | 6 |
Trials
Showing 76 to 100 of 402. Each trial links to its page on Pharma Observatory.
302 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.